Scandinavian Real Heart AB (Publ) (HEART.ST)
SEK 13.55
(-6.55%)
SEK 13.55
(-6.55%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -50.21 Million SEK | -508.69% |
| 2022 | 12.28 Million SEK | 70.65% |
| 2021 | 7.2 Million SEK | 2063.74% |
| 2020 | 332.76 Thousand SEK | -91.6% |
| 2019 | 3.95 Million SEK | 304.99% |
| 2018 | -1.93 Million SEK | -35.36% |
| 2017 | -1.42 Million SEK | 62.49% |
| 2016 | -3.8 Million SEK | -151.67% |
| 2015 | -1.51 Million SEK | -768.13% |
| 2014 | 226.25 Thousand SEK | 50973.81% |
| 2013 | 443.00 SEK | 0.0% |
| 2012 | - SEK | -100.0% |
| 2011 | 1.00 SEK | -91.67% |
| 2010 | 12.00 SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -520.16 Thousand SEK | 89.03% |
| 2024 Q1 | -4.74 Million SEK | -299.1% |
| 2023 FY | -50.21 Million SEK | -508.69% |
| 2023 Q2 | 3.5 Million SEK | -14.18% |
| 2023 Q1 | 4.07 Million SEK | 212.95% |
| 2023 Q3 | 4.18 Million SEK | 19.65% |
| 2023 Q4 | 2.38 Million SEK | -43.15% |
| 2022 Q1 | 4.87 Million SEK | 171.04% |
| 2022 FY | 12.28 Million SEK | 70.65% |
| 2022 Q4 | -3.61 Million SEK | -122.72% |
| 2022 Q3 | 15.89 Million SEK | 94.07% |
| 2022 Q2 | 8.19 Million SEK | 68.15% |
| 2021 Q2 | 4.98 Million SEK | -12.96% |
| 2021 FY | 7.2 Million SEK | 2063.74% |
| 2021 Q1 | 5.73 Million SEK | 6098.06% |
| 2021 Q4 | -6.85 Million SEK | -305.55% |
| 2021 Q3 | 3.33 Million SEK | -33.13% |
| 2020 Q2 | 2.17 Million SEK | -42.01% |
| 2020 Q1 | 3.75 Million SEK | 0.0% |
| 2020 Q3 | 3.08 Million SEK | 41.62% |
| 2020 Q4 | -95.56 Thousand SEK | -103.1% |
| 2020 FY | 332.76 Thousand SEK | -91.6% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q4 | - SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 FY | 3.95 Million SEK | 304.99% |
| 2019 Q1 | - SEK | -100.0% |
| 2018 FY | -1.93 Million SEK | -35.36% |
| 2018 Q4 | 39.5 Thousand SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q1 | - SEK | -100.0% |
| 2017 Q3 | 111 Thousand SEK | 0.0% |
| 2017 FY | -1.42 Million SEK | 62.49% |
| 2017 Q1 | 49.99 Thousand SEK | 0.0% |
| 2017 Q2 | - SEK | -100.0% |
| 2017 Q4 | 312.97 Thousand SEK | 181.96% |
| 2016 Q1 | 66.01 Thousand SEK | 0.0% |
| 2016 FY | -3.8 Million SEK | -151.67% |
| 2016 Q4 | - SEK | -100.0% |
| 2016 Q3 | 66.65 Thousand SEK | 0.0% |
| 2016 Q2 | - SEK | -100.0% |
| 2015 Q1 | 80.44 Thousand SEK | -57.17% |
| 2015 FY | -1.51 Million SEK | -768.13% |
| 2015 Q4 | - SEK | -100.0% |
| 2015 Q3 | 4918.00 SEK | -84.95% |
| 2015 Q2 | 32.68 Thousand SEK | -59.37% |
| 2014 FY | 226.25 Thousand SEK | 50973.81% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 Q4 | 187.83 Thousand SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 FY | 443.00 SEK | 0.0% |
| 2012 FY | - SEK | -100.0% |
| 2011 FY | 1.00 SEK | -91.67% |
| 2010 FY | 12.00 SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | 1048.033% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 116.706% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 116.706% |
| Arcoma AB | 11.07 Million SEK | 553.593% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | 135.874% |
| BICO Group AB (publ) | 1.83 Billion SEK | 102.743% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | 120.11% |
| CellaVision AB (publ) | 463.04 Million SEK | 110.845% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | 1775.586% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | -76.734% |
| C-Rad AB (publ) | 66.01 Million SEK | 176.07% |
| Duearity AB (publ) | -4.17 Million SEK | -1101.946% |
| Dignitana AB (publ) | 58.97 Million SEK | 185.156% |
| Episurf Medical AB (publ) | -41.8 Million SEK | -20.137% |
| Getinge AB (publ) | 13.43 Billion SEK | 100.374% |
| Iconovo AB (publ) | 17.57 Million SEK | 385.688% |
| Integrum AB (publ) | 690.56 Thousand SEK | 7371.949% |
| Luxbright AB (publ) | -2.79 Million SEK | -1695.479% |
| Mentice AB (publ) | 236.38 Million SEK | 121.244% |
| OssDsign AB (publ) | 83.64 Million SEK | 160.036% |
| Paxman AB (publ) | 12.61 Million SEK | 497.982% |
| Promimic AB (publ) | 38.51 Million SEK | 230.384% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 1.055% |
| SciBase Holding AB (publ) | 16.03 Million SEK | 413.134% |
| ScandiDos AB (publ) | 47.55 Million SEK | 205.598% |
| Sectra AB (publ) | 557.55 Million SEK | 109.007% |
| Sedana Medical AB (publ) | 108.98 Million SEK | 146.079% |
| Senzime AB (publ) | 8.33 Million SEK | 702.198% |
| SpectraCure AB (publ) | -9.22 Million SEK | -444.479% |
| Stille AB | 132.17 Million SEK | 137.994% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 102.539% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 112.045% |